Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
Huangqi sanqi mixture inhibits lncRNA Gm51500/Adam12 axis to improve renal fibrosis in CKD
LIN Jingyi1, HAN Rangyue1, XU Linghui1, TAN Ruizhi1, SU Hongwei2, WANG Li1
1Research Center of Intergated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China; 2Department of Urology, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China
LIN Jingyi, HAN Rangyue, XU Linghui, TAN Ruizhi, SU Hongwei, WANG Li. Huangqi sanqi mixture inhibits lncRNA Gm51500/Adam12 axis to improve renal fibrosis in CKD[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 750-762.
SUN Yuesheng, QU Qiang, PAN Jianghua, TONG Xiaochun, CHEN Ende, QU Jian.
Role of lncRNAs in colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 222-227.